Nevertheless, given the NAFLD/NASH results, in our view, the role of adiponectin depends on the different isoforms and receptors involved as well as on the type of liver and surgical conditions (as discussed in Section 5 and Section 6 of the current review). The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.